Compare PDLB & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDLB | CLPT |
|---|---|---|
| Founded | 1960 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.1M | 467.9M |
| IPO Year | 2021 | 2009 |
| Metric | PDLB | CLPT |
|---|---|---|
| Price | $20.29 | $13.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 63.0K | ★ 490.6K |
| Earning Date | 04-24-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 160.87 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | $28.61 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $13.91 | $8.27 |
| 52 Week High | $21.10 | $30.10 |
| Indicator | PDLB | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 36.84 |
| Support Level | $19.66 | $12.47 |
| Resistance Level | $20.81 | $13.59 |
| Average True Range (ATR) | 0.40 | 0.82 |
| MACD | -0.01 | -0.22 |
| Stochastic Oscillator | 56.12 | 2.68 |
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.